BSECompany Update2 Nov 2026 · 2 Nov 2026, 03:13 pm
Intimation of Investor's Conference Call
SMS Pharmaceuticals Ltd · 532815
✦ AI SummaryResults
SMS Pharmaceuticals Ltd will announce its Q2 and H1 FY27 results on November 4, 2026, and hold an earnings call on November 5, 2026, to discuss its performance.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
4cec9d4f-1328-474e-9baa-4cc366398d19.pdf
View document text
Date: 2nd November, 2026
Corporate Filings Department, Listing Compliance Department,
BSE Limited, National Stock Exchange of India Ltd.
Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block,
Dalal Street, Bandra-Kurla Complex, Bandra (E),
Mumbai- 400 001. Mumbai - 400 051.
Security Code: 532815 Symbol: SMSPHARMA
Dear Sir/Madam,
Sub: Intimation of Investor’s Conference Call
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations 2015, we are enclosing here with invitation for Investor’s
Conference Call, scheduled to be held on Thursday, 5th November, 2026 at 12:00 noon
(IST), to discuss the Company’s financial results and performance for the second
quarter and half year ended 30th September, 2026.
Please take into your records
Thanking you
Yours Faithfully
For SMS Pharmaceuticals Limited
Thirumalesh Tumma
Company Secretary
Hyderabad, November 02, 2026: SMS Pharmaceuticals Ltd, a diversified and integrated
pharmaceutical company specialising in APIs and intermediates, will announce its results for the
second quarter and half year ended September 30, 2026, on Wednesday, November 04, 2026. The
results will be available on the Company’s website, www.smspharma.com/.
The Company will hold an earnings call on Thursday, November 05, 2026, at 12 noon IST, where
senior management will discuss its results and performance.
SMS Pharmaceuticals Q2 & H1 FY27 Earnings Call on Thursday, November 05, 2026, at 12 noon IST
Conference Dial-In Information:
Diamond Pass: Please click here to pre-register for the call
+91 22 6280 1254
Universal Numbers
+91 22 7115 8043
Hong Kong – 800964448
Singapore – 8001012045
International Toll Free Numbers
UK – 08081011573
US – 18667462133
For any further information, please contact:
Company Investor relations
SMS Pharmaceuticals Ltd Eqsponent
Mr. Thirumalesh Tumma Mr. Aditya Dutta
Email: complianceofficer@smspharma.com Email: smspharma.IR@eqsponent.com